Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Prometheus Biosciences, Inc. (RXDX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Prometheus Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1718852.
Total stock buying since 2021: $54,235,500.
Total stock sales since 2021: $117,606,180.
Total stock option exercises since 2021: $1,082,283.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 1,020,000 | $117,606,180 | 355,693 | $1,037,623 |
| 2021 | 2,854,500 | $54,235,500 | 0 | $0 | 15,400 | $44,660 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 0 | $0 | 0 | $0 | 200,693 | $524,123 |
| 2023-04 | 0 | $0 | 10,000 | $1,084,200 | 10,000 | $37,000 |
| 2023-03 | 0 | $0 | 911,320 | $104,661,712 | 46,320 | $151,384 |
| 2023-02 | 0 | $0 | 68,680 | $8,290,518 | 68,680 | $234,116 |
| 2023-01 | 0 | $0 | 30,000 | $3,569,750 | 30,000 | $91,000 |
| 2021-12 | 0 | $0 | 0 | $0 | 15,400 | $44,660 |
| 2021-03 | 2,854,500 | $54,235,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-02 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 122,531 | 2.30 | 281,821 |
| 2023-06-02 | Marshall Keith W (Chief Financial Officer) | Option Ex | 78,162 | 3.10 | 242,302 |
| 2023-04-05 | Marshall Keith W (Chief Financial Officer) | Sale | 10,000 | 108.42 | 1,084,200 |
| 2023-04-05 | Marshall Keith W (Chief Financial Officer) | Option Ex | 10,000 | 3.70 | 37,000 |
| 2023-03-15 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 25,000 | 116.14 | 2,903,500 |
| 2023-03-15 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 25,000 | 2.90 | 72,500 |
| 2023-03-08 | Cedars Sinai Intellectual Property Co (10% Owner) | Sale | 865,000 | 114.59 | 99,120,350 |
| 2023-03-06 | Marshall Keith W (Chief Financial Officer) | Sale | 10,000 | 122.13 | 1,221,300 |
| 2023-03-06 | Marshall Keith W (Chief Financial Officer) | Option Ex | 10,000 | 3.70 | 37,000 |
| 2023-03-03 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 10,620 | 125.13 | 1,328,880 |
| 2023-03-03 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 10,620 | 3.70 | 39,294 |
| 2023-03-01 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 700 | 125.26 | 87,682 |
| 2023-03-01 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 700 | 3.70 | 2,590 |
| 2023-02-17 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 13,680 | 125.10 | 1,711,368 |
| 2023-02-17 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 13,680 | 3.70 | 50,616 |
| 2023-02-16 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 25,000 | 119.87 | 2,996,750 |
| 2023-02-16 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 25,000 | 3.70 | 92,500 |
| 2023-02-15 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 25,000 | 119.42 | 2,985,500 |
| 2023-02-15 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 25,000 | 2.90 | 72,500 |
| 2023-02-15 | Marshall Keith W (Chief Financial Officer) | Sale | 5,000 | 119.38 | 596,900 |
| 2023-02-15 | Marshall Keith W (Chief Financial Officer) | Option Ex | 5,000 | 3.70 | 18,500 |
| 2023-01-17 | Mckenna Mark C. (Chairman, President & CEO) | Sale | 25,000 | 118.99 | 2,974,750 |
| 2023-01-17 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 25,000 | 2.90 | 72,500 |
| 2023-01-17 | Marshall Keith W (Chief Financial Officer) | Sale | 5,000 | 119.00 | 595,000 |
| 2023-01-17 | Marshall Keith W (Chief Financial Officer) | Option Ex | 5,000 | 3.70 | 18,500 |
| 2021-12-01 | Mckenna Mark C. (Chairman, President & CEO) | Option Ex | 15,400 | 2.90 | 44,660 |
| 2021-03-16 | Cormorant Private Healthcare Fund Iii Lp | Buy | 375,000 | 19.00 | 7,125,000 |
| 2021-03-16 | Stenhouse Mark (Chief Operating Officer) | Buy | 14,000 | 19.00 | 266,000 |
| 2021-03-16 | Wong Roderick | Buy | 800,000 | 19.00 | 15,200,000 |
| 2021-03-16 | Adams Helen C. (Director) | Buy | 500 | 19.00 | 9,500 |
| 2021-03-16 | Papa Joseph C (Director) | Buy | 15,000 | 19.00 | 285,000 |
| 2021-03-16 | Edelman Joseph (10% Owner) | Buy | 850,000 | 19.00 | 16,150,000 |
| 2021-03-16 | Cohen Steven A/sac Capital Mgmt Lp (Other) | Buy | 800,000 | 19.00 | 15,200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RXDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Prometheus Biosciences, Inc. (symbol RXDX, CIK number 1718852) see the Securities and Exchange Commission (SEC) website.